STOCK TITAN

Sotera Health Company - SHC STOCK NEWS

Welcome to our dedicated page for Sotera Health Company news (Ticker: SHC), a resource for investors and traders seeking the latest updates and insights on Sotera Health Company stock.

Sotera Health Company (Nasdaq: SHC) is a leading global provider of sterilization, lab testing, and advisory services, primarily serving the medical device, pharmaceutical, and food industries. The company operates through three main segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics offers terminal sterilization and irradiation services, including gamma and electron beam irradiation, and EO processing. Nordion supplies Co-60 and gamma irradiators, which are critical for the gamma sterilization process. Nelson Labs specializes in outsourced microbiological and analytical chemistry testing.


The company is known for its commitment to ensuring the safety and quality of healthcare products through its comprehensive suite of services. Sotera Health’s lab services cover analytical chemistry, medical device testing, pharmaceutical lab testing, and microbiology testing, helping clients identify and mitigate risks. The advisory segment supports clients in navigating regulatory requirements throughout the product lifecycle.


Recently, Sotera Health has achieved significant milestones, including a 6.7% increase in net revenues for its Sterigenics segment in Q3 2023, driven by favorable pricing and currency exchange rates. Nordion reported a 14.3% increase in net revenues, reflecting robust demand for its services.


Despite challenges, the company has shown resilience, evidenced by a 5.8% increase in third-quarter 2023 net revenues to $263 million. However, a net loss of $14 million was reported due to a $35 million legal settlement. Sotera Health’s ongoing projects include expanding its service offerings and enhancing operational efficiencies.


Headquartered in Cleveland, Ohio, the company had $2.3 billion in total debt and $245 million in cash equivalents as of September 30, 2023, reflecting a strong financial position to support its strategic initiatives. The company continues to focus on its mission of 'Safeguarding Global Health®.'

Rhea-AI Summary

Sotera Health Company (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has announced its plans to release second-quarter 2024 financial results on Monday, August 5, 2024, before the market opens. The company will hold a conference call at 9:00 a.m. Eastern Time to discuss operating highlights and financial results.

To participate in the live call, investors can dial 1-844-481-2916 from the United States or 1-412-317-0709 from other locations. A live webcast of the conference call will be available on the company's website, along with accompanying materials. A replay of the webcast will be available later on the same day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
-
Rhea-AI Summary

Sotera Health (Nasdaq: SHC) has announced the successful closing of a $1.51 billion Term Loan B and $750 million in senior secured notes, both maturing in 2031. The company will use the proceeds to refinance its existing $1.76 billion and $496.3 million Term Loan B facilities. This refinancing is expected to save approximately $5 million in interest expenses for 2024, reducing the projected interest expense to $165-175 million. Term Loan B offers a variable interest rate with options for SOFR-based or alternate base rate loans, and is prepayable without penalties after six months. The senior secured notes carry an interest rate of 7.375% per annum, payable semi-annually. This move is seen as favorable and reflects the market's confidence in Sotera Health's business strength.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
-
Rhea-AI Summary

Sotera Health reported positive financial results for the first quarter of 2024, with a 12.5% increase in net revenues to $248 million compared to the same period in 2023. Net income also saw a significant improvement, reaching $6 million or $0.02 per diluted share. Adjusted EBITDA increased by 13.7% to $112 million, and Adjusted EPS remained steady at $0.13. The company reaffirmed its 2024 outlook, anticipating continued growth and navigating market challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.19%
Tags
Rhea-AI Summary
Sotera Health Company (Nasdaq: SHC) announces the release of its first-quarter financial results on May 2, 2024. Management will host a conference call to discuss operating highlights and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
-
Rhea-AI Summary
Sotera Health Company (SHC) announced a secondary offering of 25,000,000 shares of common stock at $14.75 per share, with selling stockholders including affiliates of Warburg Pincus LLC and GTCR LLC. The Company will not receive any proceeds from the offering, expected to close on March 4, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
-
Rhea-AI Summary
Sotera Health Company announces a secondary offering of 25,000,000 shares of common stock by selling stockholders, including affiliates of Warburg Pincus LLC and GTCR, LLC. Underwriters have an option to purchase an additional 3,750,000 shares. The Company will not receive proceeds from the Offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.75%
Tags
Rhea-AI Summary
Sotera Health Company (SHC) reported positive financial results for Q4 2023 and full-year 2023, with net revenues increasing by 4.5% to $1.05 billion and Adjusted EBITDA up by 4.3% to $528 million. The company also provided a full-year 2024 outlook of 4.0% - 6.0% growth for Net Revenues and Adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
-
Rhea-AI Summary
Sotera Health Company (Nasdaq: SHC) plans to release its financial results for Q4 and full-year 2023 on February 27, 2024. A conference call will follow to discuss operating highlights and financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
-
Rhea-AI Summary
Sotera Health Company (Nasdaq: SHC) delivered top-line growth in 2023, with expected full-year revenues between $1.040 billion and $1.050 billion. The company's consistent growth since going public in 2020 reinforces its critical role in global healthcare and durable business model. Chairman and CEO Michael B. Petras, Jr. provided this update during the 42nd Annual J.P. Morgan Healthcare Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.06%
Tags
none
Rhea-AI Summary
Sotera Health Company (NASDAQ: SHC) to present at the 42nd Annual J.P. Morgan Healthcare Conference. Chairman and CEO Michael B. Petras, Jr. will lead the presentation, along with other key executives, discussing the company's mission-critical sterilization solutions and lab testing services for the healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.22%
Tags
conferences

FAQ

What is the current stock price of Sotera Health Company (SHC)?

The current stock price of Sotera Health Company (SHC) is $13.6 as of January 22, 2025.

What is the market cap of Sotera Health Company (SHC)?

The market cap of Sotera Health Company (SHC) is approximately 3.8B.

What services does Sotera Health Company offer?

Sotera Health provides sterilization, lab testing, and advisory services for the medical device, pharmaceutical, and food industries.

What are the main segments of Sotera Health?

The main segments are Sterigenics, Nordion, and Nelson Labs.

How did Sotera Health perform in the third quarter of 2023?

The company reported a 5.8% increase in net revenues to $263 million but also reported a net loss of $14 million due to a legal settlement.

What are the key components of the gamma sterilization process provided by Nordion?

Nordion provides Co-60 and gamma irradiators, which are critical components of the gamma sterilization process.

What financial condition is Sotera Health in as of September 30, 2023?

Sotera Health had $2.3 billion in total debt and $245 million in unrestricted cash and cash equivalents.

What recent achievements has Sotera Health made?

Notable achievements include a 6.7% increase in Sterigenics segment revenues and a 14.3% increase in Nordion segment revenues in Q3 2023.

Where is Sotera Health headquartered?

Sotera Health is headquartered in Cleveland, Ohio.

What is the company’s mission?

Sotera Health’s mission is 'Safeguarding Global Health®.'

What are Sotera Health’s advisory services focused on?

The advisory services help clients navigate regulatory requirements throughout the product lifecycle.

What recent financial results did Sotera Health announce?

In Q3 2023, the company reported a net loss due to a legal settlement but showed resilience with revenue growth in challenging conditions.
Sotera Health Company

Nasdaq:SHC

SHC Rankings

SHC Stock Data

3.83B
153.21M
2.46%
94.63%
2.34%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States of America
BROADVIEW HEIGHTS